chalkjune73Understanding the GLP-1 Drug Supply Crisis in the United States: A Comprehensive OverviewThe pharmaceutical landscape in the United States is presently experiencing a transformative shift, driven mostly by the unprecedented demand for Glucagon-like peptide-1 (GLP-1) receptor agonists. Originally established to treat Type 2 diabetes, these medications-- including brands like Ozempic, Wegovy, Mounjaro, and Zepbound-- have ended up b |
0 entry(s) Showing 1 to 20
| Case Number | Domain(s) | Complainant | Respondent | Ruleset | Status |
